StockData
GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31

GE HealthCare Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)

Close on Oct 19, 2026

Market cap
$31.67B
P/E (TTM)
16.0
Dividend yield
0.20%

GE HealthCare Technologies Inc. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
AIS$3.77B–––$3.49B–––––––71.2%+8.0%
PDx$843.00M$770.00M$790.00M$749.00M$729.00M$632.00M$646.00M$625.00M$639.00M$599.00M$591.00M$589.00M15.9%+15.6%
PCS$675.00M$704.00M$824.00M$731.00M$778.00M$753.00M$827.00M$779.00M$772.00M$747.00M$827.00M$764.00M12.7%-13.2%
Ultrasound––––––––$823.00M$824.00M$944.00M$815.00M––
Imaging–$2.30B$2.55B$2.35B$2.20B$2.14B$2.39B$2.23B$2.17B$2.06B$2.39B$2.24B––
AVS–$1.34B$1.53B$1.30B$1.29B$1.24B$1.44B$1.22B$1.25B$1.23B$1.38B$1.21B––

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product$3.42B$3.35B$3.91B$3.38B$3.26B$3.12B$3.62B$3.20B$3.21B$3.05B$3.60B$3.19B64.5%+4.7%
Service$1.88B$1.79B$1.79B$1.77B$1.74B$1.66B$1.70B$1.66B$1.63B$1.61B$1.61B$1.64B35.5%+7.7%

By region

From the segment and revenue-disaggregation notes of GE HealthCare Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.